Yang T et al. |
The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. |
2013 |
Lipids Health Dis |
pmid:24148690
|
Podolin PL et al. |
In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23434473
|
Nelson JW et al. |
Soluble epoxide hydrolase dimerization is required for hydrolase activity. |
2013 |
J. Biol. Chem. |
pmid:23362272
|
Chen L et al. |
Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23247129
|
Oni-Orisan A et al. |
Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23000418
|
Strauss KI et al. |
Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:22922090
|
Chaudhary KR et al. |
Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:22922020
|
Anwar-Mohamed A et al. |
Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart. |
2012 |
Xenobiotica |
pmid:22680237
|
Theken KN et al. |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. |
2012 |
Atherosclerosis |
pmid:22503544
|
Zhao G et al. |
Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis. |
2012 |
Hum. Gene Ther. |
pmid:22260463
|